News

SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities

Austin, TX, September 17, 2024 — SubjectWell, provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. This strategic acquisition will enhance SubjectWell’s ability to connect patients to transformative healthcare across all geographies.      The integration of

WindRose Health Investors Completes Majority Growth Investment in SubjectWell

New York, NY, April 30, 2024 — WindRose Health Investors, LLC, (“Windrose”) the New York-based healthcare private equity firm, announced that it has completed the acquisition of SubjectWell, the patient access marketplace that connects people with health conditions to care options. The terms of the transaction were not disclosed. Using a multi-channel network and precision

SubjectWell Receives System and Organization Controls (SOC) 2 Type 2 Certification

The patient access marketplace successfully demonstrated strong data security credentials throughout comprehensive assessment AUSTIN, TX, November 14, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced it has received its System and Organization Controls (SOC) 2 Type 2 certification, a voluntary compliance standard which specifies

SubjectWell Acquires PatientCentra

Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers

SubjectWell: This Patient Connection Platform Is Aiming To Transform A $2.4 Billion Market

SubjectWell Expands Executive Leadership to Realize Growth Strategy

AUSTIN, TX, April 6, 2023 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor

Making Clinical Trials Better for Everyone in 2023

US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations

AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient

Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase.

Clinical trial recruitment platform SubjectWell scores $35M

SubjectWell collects $35M

SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases

Read full article from Austin Inno

SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options

AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s

Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals

Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S.

Bilingual staff boost Spanish speaker interest in trials: study

SubjectWell expands trial recruitment marketplace to oncology indications

SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials

AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic

Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD)

Rise of DCTs calls for elevated patient recruitment strategy

How decentralized clinical trials disrupt traditional patient recruitment

Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology.

Reify, SubjectWell partner to elevate trial recruitment

Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials

AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s

Survey reveals thoughts on trial participation from patients at-risk for liver disease